Results 161 to 170 of about 6,491 (191)

Palivizumab

Reactions Weekly, 2014
openaire   +2 more sources

Utilization and efficacy of palivizumab for children with Down syndrome

Pediatrics International, 2020
Masato Takeuchi, Koji Kawakami
exaly  

Controversies in Palivizumab Use

The Pediatric Infectious Disease Journal, 2004
Timothy P, Stevens, Caroline B, Hall
openaire   +2 more sources

Palivizumab

Drugs, 2012
Harriet M Lamb, L J Scott
exaly  

Palivizumab/ribavirin

Reactions Weekly, 2023
openaire   +1 more source

Evaluation of the Safety of Palivizumab in the Second Season of Exposure in Young Children at Risk for Severe Respiratory Syncytial Virus Infection

Drug Safety, 2012
Ian Mitchell, Jessie R Groothuis, Thierry Lacaze-Masmonteil   +2 more
exaly  

Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants

Human Vaccines and Immunotherapeutics, 2014
Christopher S Ambrose, Michael Forbes
exaly  

The cost effectiveness of palivizumab: a systematic review of the evidence

Journal of Medical Economics, 2010
Krista L Lanctôt, Bosco Paes, Kelly Smart   +2 more
exaly  

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants

Infectious Diseases and Therapy, 2017
Kimmie K McLaurin
exaly  

Palivizumab

Reactions Weekly, 2010
openaire   +1 more source